SHARDACROP — Sharda Cropchem Balance Sheet
0.000.00%
- IN₹87.42bn
- IN₹80.31bn
- IN₹52.68bn
Annual balance sheet for Sharda Cropchem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,004 | 2,135 | 3,610 | 5,195 | 7,118 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 16,484 | 19,037 | 15,748 | 20,519 | 23,893 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 28,515 | 32,582 | 29,379 | 35,864 | 44,381 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 144 | 49.8 | 182 | 101 | 25.3 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 37,431 | 43,508 | 40,383 | 47,249 | 57,803 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 16,918 | 19,706 | 15,805 | 19,857 | 23,862 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 18,307 | 21,188 | 18,012 | 22,243 | 26,438 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 19,125 | 22,320 | 22,371 | 25,006 | 31,365 |
| Total Liabilities & Shareholders' Equity | 37,431 | 43,508 | 40,383 | 47,249 | 57,803 |
| Total Common Shares Outstanding |